Highly efficient intranasal H5N1 vaccine based on a safe vesicular stomatitis virus (VSV) vector
The successfully developed novel 6-9ΔGΔ51+S226R-H5N1 vaccine candidate not only exhibits excellent safety and immunogenicity but also represents a powerful potential tool for the effective prevention and control of highly pathogenic avian influenza.